AVXL EPS Estimates
Anavex Life Sciences Corp.
$0.99
-$0.07(-6.66%)
31
Overall
60
Value
18
Tech
15
Quality
Market Cap
$91.71M
Volume
1.25M
52W Range
$1.07 - $7.60
Target Price
$20.00
AVXL EPS estimates: the consensus estimate for Anavex Life Sciences Corp.'s current fiscal year is -$0.33 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AVXL EPS Estimates
- EPS estimate, current quarter
- $-0.11
- EPS estimate, next quarter
- $-0.12
- EPS estimate, current year
- $-0.33
- EPS estimate, next year
- $-0.55
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.54 |
| 2024 | $-0.52 |
| 2023 | $-0.60 |
| 2021 | $-0.54 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVXL | $0.99 | -6.7% | 1.25M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Anavex Life Sciences Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW